Cargando…

Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect

BACKGROUND: A critical size bone defect is a clinical scenario in which bone is lost or excised due to trauma, infection, tumor, or other causes, and cannot completely heal spontaneously. The most common treatment for this condition is autologous bone grafting to the defect site. However, autologous...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Elijah Ejun, Zhang, Ning, Ganio, Edward A., Shen, Huaishuang, Li, Xueping, Ueno, Masaya, Utsunomiya, Takeshi, Maruyama, Masahiro, Gao, Qi, Su, Ni, Yao, Zhenyu, Yang, Fan, Gaudillière, Brice, Goodman, Stuart B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Speaking Orthopaedic Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357712/
https://www.ncbi.nlm.nih.gov/pubmed/35979174
http://dx.doi.org/10.1016/j.jot.2022.05.010
_version_ 1784763770635026432
author Huang, Elijah Ejun
Zhang, Ning
Ganio, Edward A.
Shen, Huaishuang
Li, Xueping
Ueno, Masaya
Utsunomiya, Takeshi
Maruyama, Masahiro
Gao, Qi
Su, Ni
Yao, Zhenyu
Yang, Fan
Gaudillière, Brice
Goodman, Stuart B.
author_facet Huang, Elijah Ejun
Zhang, Ning
Ganio, Edward A.
Shen, Huaishuang
Li, Xueping
Ueno, Masaya
Utsunomiya, Takeshi
Maruyama, Masahiro
Gao, Qi
Su, Ni
Yao, Zhenyu
Yang, Fan
Gaudillière, Brice
Goodman, Stuart B.
author_sort Huang, Elijah Ejun
collection PubMed
description BACKGROUND: A critical size bone defect is a clinical scenario in which bone is lost or excised due to trauma, infection, tumor, or other causes, and cannot completely heal spontaneously. The most common treatment for this condition is autologous bone grafting to the defect site. However, autologous bone graft is often insufficient in quantity or quality for transplantation to these large defects. Recently, tissue engineering methods using mesenchymal stem cells (MSCs) have been proposed as an alternative treatment. However, the underlying biological principles and optimal techniques for tissue regeneration of bone using stem cell therapy have not been completely elucidated. METHODS: In this study, we compare the early cellular dynamics of healing between bone graft transplantation and MSC therapy in a murine chronic femoral critical-size bone defect. We employ high-dimensional mass cytometry to provide a comprehensive view of the differences in cell composition, stem cell functionality, and immunomodulatory activity between these two treatment methods one week after transplantation. RESULTS: We reveal distinct cell compositions among tissues from bone defect sites compared with original bone graft, show active recruitment of MSCs to the bone defect sites, and demonstrate the phenotypic diversity of macrophages and T cells in each group that may affect the clinical outcome. CONCLUSION: Our results provide critical data and future directions on the use of MSCs for treating critical size defects to regenerate bone. Translational Potential of this article: This study showed systematic comparisons of the cellular and immunomodulatory profiles among different interventions to improve the healing of the critical-size bone defect. The results provided potential strategies for designing robust therapeutic interventions for the unmet clinical need of treating critical-size bone defects.
format Online
Article
Text
id pubmed-9357712
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Chinese Speaking Orthopaedic Society
record_format MEDLINE/PubMed
spelling pubmed-93577122022-08-16 Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect Huang, Elijah Ejun Zhang, Ning Ganio, Edward A. Shen, Huaishuang Li, Xueping Ueno, Masaya Utsunomiya, Takeshi Maruyama, Masahiro Gao, Qi Su, Ni Yao, Zhenyu Yang, Fan Gaudillière, Brice Goodman, Stuart B. J Orthop Translat Original Article BACKGROUND: A critical size bone defect is a clinical scenario in which bone is lost or excised due to trauma, infection, tumor, or other causes, and cannot completely heal spontaneously. The most common treatment for this condition is autologous bone grafting to the defect site. However, autologous bone graft is often insufficient in quantity or quality for transplantation to these large defects. Recently, tissue engineering methods using mesenchymal stem cells (MSCs) have been proposed as an alternative treatment. However, the underlying biological principles and optimal techniques for tissue regeneration of bone using stem cell therapy have not been completely elucidated. METHODS: In this study, we compare the early cellular dynamics of healing between bone graft transplantation and MSC therapy in a murine chronic femoral critical-size bone defect. We employ high-dimensional mass cytometry to provide a comprehensive view of the differences in cell composition, stem cell functionality, and immunomodulatory activity between these two treatment methods one week after transplantation. RESULTS: We reveal distinct cell compositions among tissues from bone defect sites compared with original bone graft, show active recruitment of MSCs to the bone defect sites, and demonstrate the phenotypic diversity of macrophages and T cells in each group that may affect the clinical outcome. CONCLUSION: Our results provide critical data and future directions on the use of MSCs for treating critical size defects to regenerate bone. Translational Potential of this article: This study showed systematic comparisons of the cellular and immunomodulatory profiles among different interventions to improve the healing of the critical-size bone defect. The results provided potential strategies for designing robust therapeutic interventions for the unmet clinical need of treating critical-size bone defects. Chinese Speaking Orthopaedic Society 2022-08-04 /pmc/articles/PMC9357712/ /pubmed/35979174 http://dx.doi.org/10.1016/j.jot.2022.05.010 Text en © 2022 Published by Elsevier B.V. on behalf of Chinese Speaking Orthopaedic Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Huang, Elijah Ejun
Zhang, Ning
Ganio, Edward A.
Shen, Huaishuang
Li, Xueping
Ueno, Masaya
Utsunomiya, Takeshi
Maruyama, Masahiro
Gao, Qi
Su, Ni
Yao, Zhenyu
Yang, Fan
Gaudillière, Brice
Goodman, Stuart B.
Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
title Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
title_full Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
title_fullStr Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
title_full_unstemmed Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
title_short Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
title_sort differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357712/
https://www.ncbi.nlm.nih.gov/pubmed/35979174
http://dx.doi.org/10.1016/j.jot.2022.05.010
work_keys_str_mv AT huangelijahejun differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT zhangning differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT ganioedwarda differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT shenhuaishuang differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT lixueping differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT uenomasaya differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT utsunomiyatakeshi differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT maruyamamasahiro differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT gaoqi differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT suni differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT yaozhenyu differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT yangfan differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT gaudillierebrice differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect
AT goodmanstuartb differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect